Earth Science Tech Inc (OTCMKTS:ETST) a unique biotech firm focused on CBD research and development, nutraceuticals, pharmaceuticals, cannabis-industrial hemp and cannabinoid research reported that four new doctors and scientists have joined the firm’s Advisory Board.
ETST plan of recruiting industry professionals to help expand and enhance the advancement of CBD therapeutic Indications, technology, IP, treatments and R&D. These distinguished doctors and scientists will serve on the advisory board for company and/or its two wholly owned subsidiary firms, Earth Science Pharmaceutical Inc and Cannabis Therapeutics Inc.
Dr. Laurent Azoulay, Ph.D., has become the part of both Earth Science Pharmaceutical Inc. as well as Cannabis Therapeutics Inc. Advisory Boards. He serves as an Associate Professor of Oncology at renowned McGill University, where he studies cancer pharmacoepidemiology, which comprises assessing the safety of cancer medications at a societal level.
Dr. Chandra Panchal, PhD. marks the next person to join the Advisory Board of Earth Science and its two subsidiary firms. He is an entrepreneur with an extensive experience and expertise acquired from almost 28 years of experience in the pharmaceutical/ biotech sector.
Dr. Domenico Fuoco, PhD. has been included in the Advisory Board of the Cannabis Therapeutics Inc. He has more than 16 years of experience in the R&D of unique solutions for the pharma industry. Dr. Fuoco was educated at the prominent Department of Oncology of MUHC, from 2012 to 2015. He also worked on the next-gen of drugs for AVEO Oncology and Helsinn Therapeutics.
Calvin Higgins, M.D., has been included in the Advisory Board of Earth Science Tech Inc. He is board-approved in internal medicine. Dr. Higgins was born in Kingston, and came to the U.S. in 1979. He has an abundant core for alternative drugs. In fact, he always inspires patients to pursue lifestyle changes in diet, meditation, mental wellness and exercise, just to name a few.